As a part of the Luye Life Science Group, we are a B2B partner to the global pharmaceutical industry in the development and manufacture of drugs in modified dosage forms.

Our primary focus is on Transdermal Therapeutic Systems (TTS), which we develop and produce throughout the entire process chain, both in-house and for client orders. 

We are also currently the second-largest manufacturer of active substance patches (TTS) in Europe and are the only manufacturer to have two completely separate production facilities for the production of active substance patches (plant 1) and hormone patches (plant 2) to avoid risking mutual contamination (drug safety!).